Close X
Other videos you might like

Recent Videos


ACC 23 Expert Consensus Decision Pathway on Cardiac Amyloidosis

Michelle Kittleson,

Watch time: 6m 19s


AHA 22 Late-Breaking Science Highlights With Dr Joseph Hill

Joseph A Hill,

Watch time: 5m 4s


AHA 22: Results of the CRISPR-Cas9 First-in-Human Trial

Julian Gillmore,

Watch time: 8m 12s


HF 22: HELIOS-A: Vutrisiran in Patients with hATTR Amyloidosis

Pablo Garcia-Pavia,


2022 AHA/ACC/HFSA Guideline for HF Management: Highlights & Implementation

Michelle Kittleson,

Role of T1 Mapping in Inherited Cardiomyopathies

European Cardiology Review 2016;11(2):96–101

The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy

Arrhythmia & Electrophysiology Review 2016;5(3):197–202

Cardiac Amyloid – An Update

European Cardiology Review 2015;10(2):113–7

Novel Imaging Techniques for Heart Failure

Cardiac Failure Review 2016;2(1):27–34

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?

Cardiac Failure Review 2020;6:e21.

Implications of Extra-cardiac Disease in Patient Selection for Heart Transplantation: Considerations in Cardiac Amyloidosis

Cardiac Failure Review 2023;9:e01.

Arrhythmias in Chronic Kidney Disease

European Cardiology Review 2022;17:e05.

Amyloid Heart Disease

US Cardiology Review 2018;12(2):113–8.

Clinical Use of Cardiac Magnetic Resonance in Systemic Heart Disease

European Cardiology Review 2014;9(1):21–7

Where's the Beef? A Case of Left Ventricular Hypertrophy that Isn't

American Heart Hospital Journal 2009;7(1):58–61